Limestone Investment Advisors LP
Position in TMO — Thermo Fisher Scientific Inc.
CIK 2075597
NEW YORK, NY
Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
3 quarters on record
Derivatives in TMO
reported options exposure · as of Jun 30, 2026CallValue
$1,002,720
CallShares
2,000
PutValue
$952,584
PutShares
1,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
All Filings in TMO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,002,720 | 2,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $952,584 | 1,900 | Put | Sole | 2026-08-14 | |
| 2025-09-30 | $2,231,092 | 4,600 | Call | Sole | 2025-11-13 | |
| 2025-09-30 | $1,406,558 | 2,900 | Put | Sole | 2025-11-13 | |
| 2025-06-30 | $689,282 | 1,700 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $446,006 | 1,100 | Call | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||